Japanese Encephalitis (JE) - Cases and Preparedness in Gaya Region of Bihar, India
Authors/Creators
- 1. Senior Resident, Department of Microbiology, AIIMS Patna, Bihar, India
- 2. Tutor, Department of Microbiology, ANMM College Gaya, Bihar, India
- 3. Associate Professor, Department of Microbiology, ANMM College Gaya, Bihar, India
- 4. Assistant Professor, Department of Microbiology, ANMM College Gaya, Bihar, India
Description
Japanese Encephalitis (JE) continues to pose a serious and significant public health problem in medium-endemic Central India. JE is mainly affects humans with an estimated 70,000 cases every year, of which 86% are from two Asian countries, India and China. The national incidence rate of JE was 1.08 cases per 1,000,000 populations during 2013–2021. In Bihar, the annual incidence rate was 0.55–1.78 per 100000 population during 2009–2014, indicating higher incidence than national rate. Affected person show mild to severe clinical illness with permanent neurologic or psychiatric sequelae among survivor and till now there is no effective antiviral drug exists. Therefore, an enhanced surveillance system is essential for planning and development of control/preventive measures against JE. The aim of the present study is to estimate cases of JE and their seasonal trends in Gaya region of Bihar. The seroprevalence data of one year (January 2021 to December 2021) in samples obtained from suspected JE patients from A.N.M. Medical College & Hospital, Gaya were analyzed. A total number of 35 suspected pediatric cases were studied. Out of these 35 suspected samples tested for JE IgM antibody by IgM-capture ELISA test, 04 (11.42%) were found to be positive for IgM antibody against JE virus. In this study of JE burden a male preponderance were found and all are in pediatric age group (< 16 Yrs). Till now there is no effective antiviral agent against JE virus, therefore effective JE vaccination remains as the sole strategy for control and prevention of JE. The case surveillance should have mandatory notification system that requires all medical practitioners to report clinically suspected and laboratory-confirmed cases within 24 hours, which may help to find out focus of infection and thus to control the spread.
Abstract (English)
Japanese Encephalitis (JE) continues to pose a serious and significant public health problem in medium-endemic Central India. JE is mainly affects humans with an estimated 70,000 cases every year, of which 86% are from two Asian countries, India and China. The national incidence rate of JE was 1.08 cases per 1,000,000 populations during 2013–2021. In Bihar, the annual incidence rate was 0.55–1.78 per 100000 population during 2009–2014, indicating higher incidence than national rate. Affected person show mild to severe clinical illness with permanent neurologic or psychiatric sequelae among survivor and till now there is no effective antiviral drug exists. Therefore, an enhanced surveillance system is essential for planning and development of control/preventive measures against JE. The aim of the present study is to estimate cases of JE and their seasonal trends in Gaya region of Bihar. The seroprevalence data of one year (January 2021 to December 2021) in samples obtained from suspected JE patients from A.N.M. Medical College & Hospital, Gaya were analyzed. A total number of 35 suspected pediatric cases were studied. Out of these 35 suspected samples tested for JE IgM antibody by IgM-capture ELISA test, 04 (11.42%) were found to be positive for IgM antibody against JE virus. In this study of JE burden a male preponderance were found and all are in pediatric age group (< 16 Yrs). Till now there is no effective antiviral agent against JE virus, therefore effective JE vaccination remains as the sole strategy for control and prevention of JE. The case surveillance should have mandatory notification system that requires all medical practitioners to report clinically suspected and laboratory-confirmed cases within 24 hours, which may help to find out focus of infection and thus to control the spread.
Files
IJPCR,Vol16,Issue8,Article155.pdf
Files
(448.1 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:ce7c130dafb54b49d7b7ccc7e06dfe52
|
448.1 kB | Preview Download |
Additional details
Dates
- Accepted
-
2024-07-26
Software
- Repository URL
- https://impactfactor.org/PDF/IJPCR/16/IJPCR,Vol16,Issue8,Article155.pdf
- Development Status
- Active
References
- 1. Tandale BV, Bondre VP, Sapkal GN, Gopalkrishna V, Gurav YK, Rao RK, Qazi MS, Narang R, Guduru VK, Niswade AK, Jain M, Pediatric Viral Encephalitis Study Group Childhood encephalitis hospitalizations associated with virus agents in medium-endemic states in India. J Clin Virol. 2021; 144:104970. doi: 10.1016/j.jcv.2021.104970. 2. L. Turtle, H.E. Brindle, W. William Schluter, B. Faragher, A. Rayamajhi, R. Bohara, et al. 3. Low population Japanese encephalitis virus (JEV) seroprevalence in Udayapur district, Nepal, three years after a JE vaccination programme: A case for further catch-up campaigns? 4. World Health Organization. Japanese encephalitis (JE) reported cases and incidence. https://immunizationdata.who.int/pages/incide nce/JAPENC.html?CODE=Global&YEAR. Accessed 30 Sept 2022. 5. Kumar P, Pisudde PM, Sarthi PP, Sharma MP, Keshri VR. Status and trend of acute encephalitis syndrome and Japanese encephalitis in Bihar, India. Natl Med J India. 2017;30(6):317– 320. doi: 10.4103/0970-258X.239070. 6. Textbook of Microbiology; Ananthanarayan and Paniker 10th Edition. 7. https://www.uptodate.com/contents/japaneseencephalitis/print#:~:text=Japanese%20encephalitis%20 virus%20(JEV)%2C,on%20its%20frequency%2 0and%20severity.www.who.int/newsroom/fact-sheets/detail/japanese-encephalitis 8. Tsai TF. Japanese encephalitis vaccines. 1990. [cited 2008 Jul 30]. Available from http:// www.cdc.gov/ncidod/dvbid/pubs/je-pubs.htm 9. Waller, C.; Tiemensma, M.; Currie, B.J.; Williams, D.T.; Baird, R.W.; Krause, V.L. Japanese Encephalitis in Australia—A Sentinel Case. N. Engl. J. Med. 2022, 387, 661–662. 10. https://ncvbdc.mohfw.gov.in/index1.php?lang =1&level=2&sublinkid=5926&lid=3760 11. National Vector Borne Diseases Control Programme. Directorate General of Health Services. Ministry of Health and Family Welfare, Government of India, New Delhi. https://nvbdcp.gov.in/index1.php?lang=1&l evel=1&sublinkid=5773&lid=3693. Accessed 30 Sept 2022. 12. Vasanthapuram R, Shahul Hameed SK, Desai A, et al. Dengue virus is an under-recognised causative agent of acute encephalitis syndrome (AES): results from a four-year AES surveillance study of Japanese encephalitis in selected states of India. Int J Infect Dis. 2019;84: S19– S24. doi: 10.1016/j.ijid.2019.01.008.